Quoting myself <https://np.reddit.com/r/MapPorn/comments/1md4wde/the_most_valuable_companies_in_major_eu_economies/n6135h6/?context=3 https://np.reddit.com/r/Ma

Quoting myself <https://np.reddit.com/r/MapPorn/comments/1md4wde/the_most_valuable_companies_in_major_eu_economies/n6135h6/?context=3 https://np.reddit.com/r/MapPorn/comments/1md4wde/the_most_va...>: >Novo Nordisk did not file for a renewal because of a mistake, or someone going on vacation, or anything like that. >Novo Nordisk decided that the additional years of patent protection were not worth it compared to the advantage of the drug no longer being under the jurisdiction of the PMPRB <https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Review_Board https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Revie...>. Whether that decision was financially correct in light of GLP-1's subsequent application to weight loss, I do not know. However, again, it was not a silly mistake on Novo Nordisk's part.